The company provides a wide range of diagnostic services, including dried blood spot cards, biotech and pharma research services, and genetic testing services. Archimedlife is dedicated to developing novel laboratory tests that make actionable health information quickly accessible, using clinical mass spectrometry, next-generation sequencing, and the development of novel assays and biomarkers. They also offer international diagnostic services for biotech and pharma companies and have an ARCHIMEDlife Research Institute for academic research, - omics, and biomarker discovery.